Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Younes

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Organic & Biomolecular Chemistry|March 1, 2017
Rapid chemoenzymatic route to glutamate transporter inhibitor l-TFB-TBOA and related amino acidsHaigen Fu, Sabry H H Younes, Mohammad Saifuddin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 7, 2011
Certolizumab pegol for active Crohn's disease: a placebo-controlled, randomized trialWilliam J Sandborn, Stefan Schreiber, Brian G Feagan, et al.
Nature Communications|May 9, 2020
Photobiocatalytic synthesis of chiral secondary fatty alcohols from renewable unsaturated fatty acidsWuyuan Zhang, Jeong-Hoo Lee, Sabry H H Younes, et al.
ACS Catalysis|March 25, 2021
Biocatalytic Aromaticity-Breaking Epoxidation of Naphthalene and Nucleophilic Ring-Opening ReactionsWuyuan Zhang, Huanhuan Li, Sabry H H Younes, et al.
The American Journal of Gastroenterology|August 12, 2021
Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver DiseaseStephen A Harrison, Seth J Baum, Nadege T Gunn, et al.
Chembiochem : a European Journal of Chemical Biology|September 8, 2018
A Photoenzymatic NADH Regeneration SystemGeorg T Höfler, Elena Fernández-Fueyo, Milja Pesic, et al.
Journal of Crohn'S & Colitis|May 17, 2018
Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe DiseaseWilliam J Sandborn, Bal R Bhandari, Charles Randall, et al.
Journal for Immunotherapy of Cancer|December 25, 2025
Influence of time-of-day of graft infusion on allogeneic hematopoietic stem cell transplantation outcomes: a validation cohort studyChiara Bernardi, Amandine Pradier, Stavroula Masouridi-Levrat, et al.
Journal of Crohn'S & Colitis|May 31, 2018
A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's DiseaseStefan Schreiber, Corey A Siegel, Keith A Friedenberg, et al.
ACS Catalysis|May 14, 2023
Structure of the Reductase Domain of a Fungal Carboxylic Acid Reductase and Its Substrate Scope in Thioester and Aldehyde ReductionBastian Daniel, Chiam Hashem, Marlene Leithold, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Organic & Biomolecular Chemistry|March 1, 2017
Rapid chemoenzymatic route to glutamate transporter inhibitor l-TFB-TBOA and related amino acidsHaigen Fu, Sabry H H Younes, Mohammad Saifuddin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 7, 2011
Certolizumab pegol for active Crohn's disease: a placebo-controlled, randomized trialWilliam J Sandborn, Stefan Schreiber, Brian G Feagan, et al.
Nature Communications|May 9, 2020
Photobiocatalytic synthesis of chiral secondary fatty alcohols from renewable unsaturated fatty acidsWuyuan Zhang, Jeong-Hoo Lee, Sabry H H Younes, et al.
ACS Catalysis|March 25, 2021
Biocatalytic Aromaticity-Breaking Epoxidation of Naphthalene and Nucleophilic Ring-Opening ReactionsWuyuan Zhang, Huanhuan Li, Sabry H H Younes, et al.
The American Journal of Gastroenterology|August 12, 2021
Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver DiseaseStephen A Harrison, Seth J Baum, Nadege T Gunn, et al.
Chembiochem : a European Journal of Chemical Biology|September 8, 2018
A Photoenzymatic NADH Regeneration SystemGeorg T Höfler, Elena Fernández-Fueyo, Milja Pesic, et al.
Journal of Crohn'S & Colitis|May 17, 2018
Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe DiseaseWilliam J Sandborn, Bal R Bhandari, Charles Randall, et al.
Journal for Immunotherapy of Cancer|December 25, 2025
Influence of time-of-day of graft infusion on allogeneic hematopoietic stem cell transplantation outcomes: a validation cohort studyChiara Bernardi, Amandine Pradier, Stavroula Masouridi-Levrat, et al.
Journal of Crohn'S & Colitis|May 31, 2018
A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's DiseaseStefan Schreiber, Corey A Siegel, Keith A Friedenberg, et al.
ACS Catalysis|May 14, 2023
Structure of the Reductase Domain of a Fungal Carboxylic Acid Reductase and Its Substrate Scope in Thioester and Aldehyde ReductionBastian Daniel, Chiam Hashem, Marlene Leithold, et al.
Pageof 9